1. Home
  2. OSRHW vs WORX Comparison

OSRHW vs WORX Comparison

Compare OSRHW & WORX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSRHW
  • WORX
  • Stock Information
  • Founded
  • OSRHW N/A
  • WORX N/A
  • Country
  • OSRHW United States
  • WORX United States
  • Employees
  • OSRHW 21
  • WORX N/A
  • Industry
  • OSRHW
  • WORX Services-Misc. Amusement & Recreation
  • Sector
  • OSRHW
  • WORX Consumer Discretionary
  • Exchange
  • OSRHW Nasdaq
  • WORX Nasdaq
  • Market Cap
  • OSRHW N/A
  • WORX N/A
  • IPO Year
  • OSRHW 2023
  • WORX N/A
  • Fundamental
  • Price
  • OSRHW N/A
  • WORX $0.44
  • Analyst Decision
  • OSRHW
  • WORX
  • Analyst Count
  • OSRHW 0
  • WORX 0
  • Target Price
  • OSRHW N/A
  • WORX N/A
  • AVG Volume (30 Days)
  • OSRHW N/A
  • WORX 296.1K
  • Earning Date
  • OSRHW N/A
  • WORX 05-15-2025
  • Dividend Yield
  • OSRHW N/A
  • WORX N/A
  • EPS Growth
  • OSRHW N/A
  • WORX N/A
  • EPS
  • OSRHW N/A
  • WORX N/A
  • Revenue
  • OSRHW N/A
  • WORX $2,897,799.00
  • Revenue This Year
  • OSRHW N/A
  • WORX N/A
  • Revenue Next Year
  • OSRHW N/A
  • WORX N/A
  • P/E Ratio
  • OSRHW N/A
  • WORX N/A
  • Revenue Growth
  • OSRHW N/A
  • WORX N/A
  • 52 Week Low
  • OSRHW N/A
  • WORX $0.39
  • 52 Week High
  • OSRHW N/A
  • WORX $3.31
  • Technical
  • Relative Strength Index (RSI)
  • OSRHW N/A
  • WORX 43.76
  • Support Level
  • OSRHW N/A
  • WORX $0.41
  • Resistance Level
  • OSRHW N/A
  • WORX $0.48
  • Average True Range (ATR)
  • OSRHW 0.00
  • WORX 0.03
  • MACD
  • OSRHW 0.00
  • WORX 0.01
  • Stochastic Oscillator
  • OSRHW 0.00
  • WORX 41.94

About OSRHW OSR Holdings Inc. Warrant

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: